Evidence map›Paper›PMID 33720976›Full record

ArticlePLoS pathogens2021

A systematic analysis of hypermucoviscosity and capsule reveals distinct and overlapping genes that impact Klebsiella pneumoniae fitness.

Laura A Mike, Andrew J Stark, Valerie S Forsyth, Jay Vornhagen, Sara N Smith, Michael A Bachman, Harry L T Mobley

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 158 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Hypermucoviscosity inJournal of bacteriology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Infection and immunity · 2026
    Article
  12. Article
  13. Genomic instability and biofilm determinants inbioRxiv : the preprint server for biology · 2026
    Article
  14. Review
  15. Article
  16. Connections betweenInfection and immunity · 2026
    Article
  17. Article
  18. Capsule Regulation ShapesInternational journal of molecular sciences · 2026
    Article
  19. The acquisition ofmBio · 2026
    Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Laura A MikeDepartment of Microbiology & Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID 0000-0002-3368-4184
Andrew J StarkDepartment of Microbiology & Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID 0000-0002-3185-2885
Valerie S ForsythDepartment of Microbiology & Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.
Jay VornhagenDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, United States of America.
Sara N SmithDepartment of Microbiology & Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.
Michael A BachmanDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, United States of America.
Harry L T MobleyDepartment of Microbiology & Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID 0000-0001-9195-7665
University of Michigan · US

Funding

Molecular Mechanisms of Microbial Pathogenesis Training ProgramT32AI007528 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARRUTHERS, VERNON BRUCE · 1998 to 2024
$6.8M
Fitness of gram-negative pathogens during bacteremiaR01AI134731 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BACHMAN, MICHAEL ABBOTT, MOBLEY, HARRY L. · 2019 to 2022
$2.8M
NIAID NIH HHS R01 AI134731NIAID NIH HHS T32 AI007528
6 · The paper itself

Abstract

Hypervirulent K. pneumoniae (hvKp) is a distinct pathotype that causes invasive community-acquired infections in healthy individuals. Hypermucoviscosity (hmv) is a major phenotype associated with hvKp characterized by copious capsule production and poor sedimentation. Dissecting the individual functions of CPS production and hmv in hvKp has been hindered by the conflation of these two properties. Although hmv requires capsular polysaccharide (CPS) biosynthesis, other cellular factors may also be required and some fitness phenotypes ascribed to CPS may be distinctly attributed to hmv. To address this challenge, we systematically identified genes that impact capsule and hmv. We generated a condensed, ordered transposon library in hypervirulent strain KPPR1, then evaluated the CPS production and hmv phenotypes of the 3,733 transposon mutants, representing 72% of all open reading frames in the genome. We employed forward and reverse genetic screens to evaluate effects of novel and known genes on CPS biosynthesis and hmv. These screens expand our understanding of core genes that coordinate CPS biosynthesis and hmv, as well as identify central metabolism genes that distinctly impact CPS biosynthesis or hmv, specifically those related to purine metabolism, pyruvate metabolism and the TCA cycle. Six representative mutants, with varying effect on CPS biosynthesis and hmv, were evaluated for their impact on CPS thickness, serum resistance, host cell association, and fitness in a murine model of disseminating pneumonia. Altogether, these data demonstrate that hmv requires both CPS biosynthesis and other cellular factors, and that hmv and CPS may serve distinct functions during pathogenesis. The integration of hmv and CPS to the metabolic status of the cell suggests that hvKp may require certain nutrients to specifically cause deep tissue infections.

Indexed as

Klebsiella InfectionsAnimalsBacterial CapsulesGenes, OverlappingGenetic FitnessHumansKlebsiella pneumoniaeMiceVirulenceViscosity

Identifiers

PMID33720976
PMCPMC7993769
OpenAlexW3137895815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.